Report of Foreign Issuer (6-k)

Date : 12/04/2017 @ 7:02AM
Source : Edgar (US Regulatory)
Stock : Gw Pharmaceuticals Plc. (PC) (GWPRF)
Quote : 9.97  -0.47 (-4.50%) @ 4:00PM

Report of Foreign Issuer (6-k)

 

United States

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

Form 6-K

 

 

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the Month of December, 2017

 

Commission File Number: 001-35892

 

 

 

GW PHARMACEUTICALS PLC

(Translation of registrant’s name into English)

 

 

 

Sovereign House

Vision Park

Histon

Cambridge CB24 9BZ

United Kingdom

(Address of principal executive offices)

 

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F   x   Form 40-F   ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨

 

 

 

 

Other Events

 

On December 4, 2017, GW Pharmaceuticals plc (the “Company”) issued a press release announcing its fourth quarter and fiscal year-end 2017 financial results and operational progress and details of a conference call to be held at 7:30 a.m. EST on December 4, 2017 to discuss the results and operational progress. The press release is attached as Exhibit 99.1 and is incorporated by reference herein.

 

The Company posted presentations at the American Epilepsy Society (AES) annual meeting held in Washington, D.C. from December 1 to December 5, 2017 with data from pivotal trials, the Company’s expanded access program and non-clinical research. There were 25 presentations, 22 of which were authored by the Company. Additionally, on December 4, 2017, the Company is hosting a scientific exhibit that covers all of the data presented over the course of the AES meeting. The presentation materials are attached as Exhibit 99.2 and are incorporated by reference herein.

  

The information contained in Exhibits 99.1 and 99.2 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, unless expressly set forth by specific reference in such a filing.

 

Exhibits

 

99.1 Press Release dated December 4, 2017

 

99.2 Presentation Materials.

 

 

 

 

 

SIGNATURES

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  GW Pharmaceuticals plc
     
  By: /s/ Adam George
  Name: Adam George
  Title: Secretary
     
Date: December 4, 2017    

 

 

 

 

Gw Pharmaceuticals Plc. (PC) (USOTC:GWPRF)
Historical Stock Chart

1 Year : From Dec 2016 to Dec 2017

Click Here for more Gw Pharmaceuticals Plc. (PC) Charts.

Gw Pharmaceuticals Plc. (PC) (USOTC:GWPRF)
Intraday Stock Chart

Today : Tuesday 12 December 2017

Click Here for more Gw Pharmaceuticals Plc. (PC) Charts.

Latest GWPRF Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.